Ophthalmology Reimbursed
Innovation Beyond Drugs: Devices, Tissue Products, and ASC Reimbursement
Ophthalmology Reimbursed is celebrating one year! In this special anniversary episode, we look back at some of the conversations, industry perspectives, and reimbursement issues that shaped our first year and look ahead to what’s coming next, including an invitation to connect with the Corcoran Consulting Group team at AAO in New Orleans. Then, we wrap up our Beyond the Bundle Series by shifting the focus from drugs to devices, tissue products, and ASC reimbursement. We break down what may be separately payable, what is typically included in the ASC facility payment, how device-intensive procedures fit into the picture, and what ASC leaders should consider before adopting a new technology. We also discuss the October 1, 2026 implementation of CPT 1084T as a timely example of why coding and reimbursement changes need to be monitored throughout the year. Join us as we celebrate our first year, close out Beyond the Bundle, and get ready for another year of practical conversations about ophthalmology coding, reimbursement, and compliance.
